Literature DB >> 7594765

K-ras mutation and pancreatic adenocarcinoma.

C Caldas1, S E Kern.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7594765     DOI： 10.1007/BF02825415

Source DB:  PubMed          Journal:  Int J Pancreatol        ISSN： 0169-4197


× No keyword cloud information.
  65 in total

1.  Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer.

Authors:  J L Cameron; D W Crist; J V Sitzmann; R H Hruban; J K Boitnott; A J Seidler; J Coleman
Journal:  Am J Surg       Date:  1991-01       Impact factor: 2.565

Review 2.  Species-specific differences in tumorigenesis and senescence.

Authors:  S S Smith
Journal:  Trends Genet       Date:  1994-09       Impact factor: 11.639

3.  Pancreatic ductal adenocarcinomas induced in Syrian hamsters by N-nitrosobis(2-oxopropyl)amine contain a c-Ki-ras oncogene with a point-mutated codon 12.

Authors:  H Fujii; H Egami; W Chaney; P Pour; J Pelling
Journal:  Mol Carcinog       Date:  1990       Impact factor: 4.784

4.  p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions.

Authors:  M S Redston; C Caldas; A B Seymour; R H Hruban; L da Costa; C J Yeo; S E Kern
Journal:  Cancer Res       Date:  1994-06-01       Impact factor: 12.701

5.  Pancreatic neoplasia induced by ras expression in acinar cells of transgenic mice.

Authors:  C J Quaife; C A Pinkert; D M Ornitz; R D Palmiter; R L Brinster
Journal:  Cell       Date:  1987-03-27       Impact factor: 41.582

6.  Protein farnesyltransferase inhibitors block the growth of ras-dependent tumors in nude mice.

Authors:  N E Kohl; F R Wilson; S D Mosser; E Giuliani; S J deSolms; M W Conner; N J Anthony; W J Holtz; R P Gomez; T J Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

7.  Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma.

Authors:  C Caldas; S A Hahn; L T da Costa; M S Redston; M Schutte; A B Seymour; C L Weinstein; R H Hruban; C J Yeo; S E Kern
Journal:  Nat Genet       Date:  1994-09       Impact factor: 38.330

8.  K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions.

Authors:  N S Pellegata; F Sessa; B Renault; M Bonato; B E Leone; E Solcia; G N Ranzani
Journal:  Cancer Res       Date:  1994-03-15       Impact factor: 12.701

9.  Frequent glycine-to-aspartic acid mutations at codon 12 of c-Ki-ras gene in human pancreatic cancer in Japanese.

Authors:  Y Nagata; M Abe; K Motoshima; E Nakayama; H Shiku
Journal:  Jpn J Cancer Res       Date:  1990-02

10.  Identification of K-ras oncogene mutations in the pure pancreatic juice of patients with ductal pancreatic cancers.

Authors:  H Watanabe; N Sawabu; H Ohta; Y Satomura; O Yamakawa; Y Motoo; T Okai; H Takahashi; T Wakabayashi
Journal:  Jpn J Cancer Res       Date:  1993-09
View more
  49 in total

1.  Association between coffee drinking and K-ras mutations in exocrine pancreatic cancer. PANKRAS II Study Group.

Authors:  M Porta; N Malats; L Guarner; A Carrato; J Rifà; A Salas; J M Corominas; M Andreu; F X Real
Journal:  J Epidemiol Community Health       Date:  1999-11       Impact factor: 3.710

Review 2.  Transgenic models of pancreatic cancer.

Authors:  Andrew M Lowy
Journal:  Int J Gastrointest Cancer       Date:  2003

3.  Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway.

Authors:  Oliver A Kent; Raghu R Chivukula; Michael Mullendore; Erik A Wentzel; Georg Feldmann; Kwang H Lee; Shu Liu; Steven D Leach; Anirban Maitra; Joshua T Mendell
Journal:  Genes Dev       Date:  2010-12-15       Impact factor: 11.361

Review 4.  Pancreatic cancer.

Authors:  C Güngör; B T Hofmann; G Wolters-Eisfeld; M Bockhorn
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

5.  Targeting reactive nitrogen species suppresses hereditary pancreatic cancer.

Authors:  Mo Li; Qian Chen; Teng Ma; Xiaochun Yu
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-19       Impact factor: 11.205

Review 6.  Primary malignant fibrous histiocytoma of the pancreas: a case with K-ras mutation and a review of the literature.

Authors:  Tomotaka Akatsu; Masashi Tsugita; Seiichi Ro; Kaori Kameyama; Masaki Kitajima
Journal:  Dig Dis Sci       Date:  2005-12       Impact factor: 3.199

7.  Prevalence and clinical significance of combined K-ras mutation and p53 aberration in pancreatic adenocarcinoma.

Authors:  S T Dergham; M C Dugan; R Kucway; W Du; D S Kamarauskiene; V K Vaitkevicius; J D Crissman; F H Sarkar
Journal:  Int J Pancreatol       Date:  1997-04

Review 8.  Molecular pathways in pancreatic carcinogenesis.

Authors:  Anne M Macgregor-Das; Christine A Iacobuzio-Donahue
Journal:  J Surg Oncol       Date:  2012-07-17       Impact factor: 3.454

Review 9.  Long non-coding RNAs in cancer invasion and metastasis.

Authors:  Xiao-han Shen; Peng Qi; Xiang Du
Journal:  Mod Pathol       Date:  2014-06-13       Impact factor: 7.842

10.  Loss of the transcription factor GLI1 identifies a signaling network in the tumor microenvironment mediating KRAS oncogene-induced transformation.

Authors:  Lisa D Mills; Yaqing Zhang; Ronald J Marler; Marta Herreros-Villanueva; Lizhi Zhang; Luciana L Almada; Fergus Couch; Cynthia Wetmore; Marina Pasca di Magliano; Martin E Fernandez-Zapico
Journal:  J Biol Chem       Date:  2013-03-12       Impact factor: 5.157
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.